93 related articles for article (PubMed ID: 9712030)
1. Protein kinase C is involved in the regulation of both signaling and adhesion mediated by DNAX accessory molecule-1 receptor.
Shibuya A; Lanier LL; Phillips JH
J Immunol; 1998 Aug; 161(4):1671-6. PubMed ID: 9712030
[TBL] [Abstract][Full Text] [Related]
2. CD28-mediated cytotoxicity by the human leukemic NK cell line YT involves tyrosine phosphorylation, activation of phosphatidylinositol 3-kinase, and protein kinase C.
Teng JM; Liu XR; Mills GB; Dupont B
J Immunol; 1996 May; 156(9):3222-32. PubMed ID: 8617944
[TBL] [Abstract][Full Text] [Related]
3. Requirement of the serine at residue 329 for lipid raft recruitment of DNAM-1 (CD226).
Shirakawa J; Shibuya K; Shibuya A
Int Immunol; 2005 Mar; 17(3):217-23. PubMed ID: 15684041
[TBL] [Abstract][Full Text] [Related]
4. DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells.
Toutirais O; Cabillic F; Le Friec G; Salot S; Loyer P; Le Gallo M; Desille M; de La Pintière CT; Daniel P; Bouet F; Catros V
Eur J Immunol; 2009 May; 39(5):1361-8. PubMed ID: 19404979
[TBL] [Abstract][Full Text] [Related]
5. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule.
Bottino C; Castriconi R; Pende D; Rivera P; Nanni M; Carnemolla B; Cantoni C; Grassi J; Marcenaro S; Reymond N; Vitale M; Moretta L; Lopez M; Moretta A
J Exp Med; 2003 Aug; 198(4):557-67. PubMed ID: 12913096
[TBL] [Abstract][Full Text] [Related]
6. LFA-1-dependent lipid raft recruitment of DNAM-1 (CD226) in CD4+ T cell.
Shirakawa J; Wang Y; Tahara-Hanaoka S; Honda S; Shibuya K; Shibuya A
Int Immunol; 2006 Jun; 18(6):951-7. PubMed ID: 16636013
[TBL] [Abstract][Full Text] [Related]
7. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.
El-Sherbiny YM; Meade JL; Holmes TD; McGonagle D; Mackie SL; Morgan AW; Cook G; Feyler S; Richards SJ; Davies FE; Morgan GJ; Cook GP
Cancer Res; 2007 Sep; 67(18):8444-9. PubMed ID: 17875681
[TBL] [Abstract][Full Text] [Related]
8. DNAM-1: an amplifier of immune responses as a therapeutic target in various disorders.
Elishmereni M; Bachelet I; Levi-Schaffer F
Curr Opin Investig Drugs; 2008 May; 9(5):491-6. PubMed ID: 18465659
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of murine DNAM-1 (CD226) and its poliovirus receptor family ligands.
Tahara-Hanaoka S; Miyamoto A; Hara A; Honda S; Shibuya K; Shibuya A
Biochem Biophys Res Commun; 2005 Apr; 329(3):996-1000. PubMed ID: 15752754
[TBL] [Abstract][Full Text] [Related]
10. cis-Determinants in the cytoplasmic domain of CEACAM1 responsible for its tumor inhibitory function.
Izzi L; Turbide C; Houde C; Kunath T; Beauchemin N
Oncogene; 1999 Sep; 18(40):5563-72. PubMed ID: 10523833
[TBL] [Abstract][Full Text] [Related]
11. The golli-myelin basic protein negatively regulates signal transduction in T lymphocytes.
Feng JM; Fernandes AO; Campagnoni CW; Hu YH; Campagnoni AT
J Neuroimmunol; 2004 Jul; 152(1-2):57-66. PubMed ID: 15223237
[TBL] [Abstract][Full Text] [Related]
12. Beta 1 integrin- and proteoglycan-mediated stimulation of T lymphoma cell adhesion and mitogen-activated protein kinase signaling by thrombospondin-1 and thrombospondin-1 peptides.
Wilson KE; Li Z; Kara M; Gardner KL; Roberts DD
J Immunol; 1999 Oct; 163(7):3621-8. PubMed ID: 10490955
[TBL] [Abstract][Full Text] [Related]
13. Identification of protein kinase C phosphorylation sites in the angiotensin II (AT1A) receptor.
Qian H; Pipolo L; Thomas WG
Biochem J; 1999 Nov; 343 Pt 3(Pt 3):637-44. PubMed ID: 10527943
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction.
Castriconi R; Dondero A; Corrias MV; Lanino E; Pende D; Moretta L; Bottino C; Moretta A
Cancer Res; 2004 Dec; 64(24):9180-4. PubMed ID: 15604290
[TBL] [Abstract][Full Text] [Related]
15. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes.
Shibuya A; Campbell D; Hannum C; Yssel H; Franz-Bacon K; McClanahan T; Kitamura T; Nicholl J; Sutherland GR; Lanier LL; Phillips JH
Immunity; 1996 Jun; 4(6):573-81. PubMed ID: 8673704
[TBL] [Abstract][Full Text] [Related]
16. Physical and functional association of LFA-1 with DNAM-1 adhesion molecule.
Shibuya K; Lanier LL; Phillips JH; Ochs HD; Shimizu K; Nakayama E; Nakauchi H; Shibuya A
Immunity; 1999 Nov; 11(5):615-23. PubMed ID: 10591186
[TBL] [Abstract][Full Text] [Related]
17. PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis.
Pende D; Bottino C; Castriconi R; Cantoni C; Marcenaro S; Rivera P; Spaggiari GM; Dondero A; Carnemolla B; Reymond N; Mingari MC; Lopez M; Moretta L; Moretta A
Mol Immunol; 2005 Feb; 42(4):463-9. PubMed ID: 15607800
[TBL] [Abstract][Full Text] [Related]
18. DNAM-1 and PVR regulate monocyte migration through endothelial junctions.
Reymond N; Imbert AM; Devilard E; Fabre S; Chabannon C; Xerri L; Farnarier C; Cantoni C; Bottino C; Moretta A; Dubreuil P; Lopez M
J Exp Med; 2004 May; 199(10):1331-41. PubMed ID: 15136589
[TBL] [Abstract][Full Text] [Related]
19. DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells.
Carlsten M; Björkström NK; Norell H; Bryceson Y; van Hall T; Baumann BC; Hanson M; Schedvins K; Kiessling R; Ljunggren HG; Malmberg KJ
Cancer Res; 2007 Feb; 67(3):1317-25. PubMed ID: 17283169
[TBL] [Abstract][Full Text] [Related]
20. Differential transcriptional regulation of CD161 and a novel gene, 197/15a, by IL-2, IL-15, and IL-12 in NK and T cells.
Azzoni L; Zatsepina O; Abebe B; Bennett IM; Kanakaraj P; Perussia B
J Immunol; 1998 Oct; 161(7):3493-500. PubMed ID: 9759869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
